Takeda Pharmaceutical: A Long-Term Cash Cow
A closer look at one of the leaders in the global Crohn's disease treatment market
Source: yahoo.com
Johnson Remicade News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Johnson Remicade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Johnson Remicade Today - Breaking & Trending Today
Herceptin shows biosimilar markets can work. To what extent is the question.
Copycat versions of branded cancer drug Herceptin led to lower biologic prices, yet the real test for biosimilars lies ahead.
Source: mmm-online.com
BioBlast w/e 17 Feb 2023: Takeda's vedolizumab trials, Organon's financial results, Biora's PGN-OB1 trials, Fresenius Kabi's pegfilgrastim, Henlius' trastuzumab, Coherus/Junshi Biosciences' toripalimab trials, Similis Bio/Novel 351K biosimilars partnership, Biocon bevacizumab FDA Complete Response Letter
Takeda published the results of Ph III trials of vedolizumab in the prevention of intestinal acute graft-versus-host disease (aGvHD) in patients…
Source: lexology.com